[Research progress and application of the homeodomain-interacting protein kinase-2]

[Article in Chinese]

Affiliations

Review

[Article in Chinese]

Wenyun Jia et al. Zhongguo Fei Ai Za Zhi. 2011 Apr.

. 2011 Apr;14(4):373-7.

doi: 10.3779/j.issn.1009-3419.2011.04.13.

¹ Department of Cellular and Molecular Biology, Beijing TB and Thoracic Tumor Research Institute, Beijing, China.

No abstract available

References

1. Kim YH, Choi CY, Lee SJ, et al. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem. 1998;273(40):25875–25879. doi: 10.1074/jbc.273.40.25875. - DOI - PubMed
1. Hofmann TG, Mincheva A, Lichter P, et al. Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34. Biochimie. 2000;82(12):1123–1127. doi: 10.1016/S0300-9084(00)01196-2. - DOI - PubMed
1. Trost M, Kochs G, Haller O. Characterization of novel serine/threonine kinase associated with nuclear bodies. J Biol Chem. 2000;275(10):7373–7377. doi: 10.1074/jbc.275.10.7373. - DOI - PubMed
1. Di SV, Blandino G, Sacchi A, et al. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene. 2004;23(30):5185–5192. doi: 10.1038/sj.onc.1207656. - DOI - PubMed
1. Engelhardt OG, Boutell C, Orr A, et al. The homeodomain-interacting kinase PKM (HIPK-2) modifes ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the postranslational modifcation of PML. Exp Cell Res. 2003;283(1):36–50. doi: 10.1016/S0014-4827(02)00025-3. - DOI - PubMed